Clinical trial
Study Evaluating PPM-204 In Subjects With Type 2 Diabetes
NCT00425919 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00425919 |
|---|---|
| Title | Study Evaluating PPM-204 In Subjects With Type 2 Diabetes |
| Official title | A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Of The Safety And Efficacy Of PPM-204 In Subjects With Type 2 Diabetes |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | PPM-204 |
| Enrollment | 500 |
| Start date | Jan 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jan 23, 2007 |
| Last update posted | Dec 27, 2007 |
| Countries | Argentina, Australia, Brazil, Canada, China, Croatia, Greece, Hong Kong, India, Italy, Mexico, Romania and 6 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: